DCM
Driehaus Capital Management’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100M | Sell |
2,310,755
-28,808
| -1% | -$1.25M | 0.8% | 22 |
|
|
2025
Q1 | $87.4M | Sell |
2,339,563
-265,747
| -10% | -$9.93M | 0.84% | 21 |
|
|
2024
Q4 | $118M | Buy |
2,605,310
+71,703
| +3% | +$3.25M | 0.97% | 16 |
|
|
2024
Q3 | $149M | Buy |
2,533,607
+415,737
| +20% | +$24.4M | 1.28% | 10 |
|
|
2024
Q2 | $83.3M | Buy |
2,117,870
+54,107
| +3% | +$2.13M | 0.81% | 27 |
|
|
2024
Q1 | $137M | Buy |
2,063,763
+734,699
| +55% | +$48.8M | 1.37% | 9 |
|
|
2023
Q4 | $37.1M | Sell |
1,329,064
-10,211
| -0.8% | -$285K | 0.45% | 63 |
|
|
2023
Q3 | $28.5M | Buy |
+1,339,275
| New | +$28.5M | 0.37% | 83 |
|